EPISODE · Jul 28, 2022 · 2 MIN
At-home ketamine therapy 'incredibly effective,' study finds; FDA approves Neuronetics' transcranial magnetic stimulation treatment for depression-related anxiety
from Becker's Healthcare Behavioral Health · host Becker's Healthcare
Randi Haseman gives updates on the Behavioral Health industry.
NOW PLAYING
At-home ketamine therapy 'incredibly effective,' study finds; FDA approves Neuronetics' transcranial magnetic stimulation treatment for depression-related anxiety
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m